Ahmed Abdelmageed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ahmed Abdelmageed has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Mark Messak
Faculty of Medicine, Helwan University, Helwan, Egypt
3 shared publications - Youssef Mandour
Faculty of Medicine, Mansoura University, Mansoura, Egypt
3 shared publications - Ahmed Negida
Department of Neurology, Virginia Commonwealth University, Richmond, VA, USA
2 shared publications - Habiba Tariq Saeed
Faculty of Medicine, Tanta University
2 shared publications - Youssef A. Khattab
Faculty of Medicine, Mansoura University, Mansoura, Egypt
2 shared publications - Abdallah Adel Nofal
Mansoura Manchester Program for Medical Education, Faculty of Medicine, Mansoura University, Mansoura, Egypt
1 shared publication
Latest Publications
- Open Access
- 31 October 2026
- Published by Springer Nature in BMC Medical Education
- Vol. 26 (1) , 1760
Cross-cultural care awareness and self-perceived skillfulness among medical students in Egypt: a national study
Background: Cross-cultural care (CCC) enables effective, patient-centered care for individuals from diverse backgrounds. Despite its importance in improving care quality and reducing health disparities, evidence on CCC among medical students in Egypt remains scarce. This study assessed medical students' cross-cultural self-perceived skillfulness and cultural awareness, examined their association, and identified sociodemographic and educational factors linked to both. Methods: A multicentric cross-sectional study was conducted between November 2025 and March 2026 across 14 Egyptian medical schools. Using convenience sampling, 1,645 medical students from all academic years and interns participated. Data were collected using an online questionnaire that included sociodemographic and educational factors, the Modified Cultural Awareness Scale (mCAS), and the Harvard CCC Survey skillfulness subscale. Statistical analyses included correlation, group comparisons, and multivariable linear regression. Results: Among 1,645 participants (mean age 21.8 ± 1.9 years; 53.7% female), the mean self-perceived cross-cultural skillfulness score was 3.55/5 (SD 0.78). Students felt most skilled in identifying a patient's Arabic literacy and taking a social history, and least skilled in counseling on complementary and alternative medicine and identifying patient mistrust. The mean total cultural awareness score was 4.69/7 (SD 0.75), highest in the Cognitive Awareness and Clinical Issues domains and lowest in General Educational and Research Experience. Higher awareness was associated with advanced English fluency and greater perceived adequacy of clinical experience and training (all p < 0.001), and skillfulness correlated positively with total awareness ( r = 0.383, p < 0.001). In multivariable analysis, advanced English fluency, prior cultural sensitivity training, and all four cultural awareness domains were independently associated with skillfulness (all p ≤ 0.036). Conclusion: Among medical students in Egypt, self-perceived cross-cultural skillfulness was at an intermediate level and was independently associated with advanced English fluency, prior cultural sensitivity training, and greater cultural awareness across all mCAS domains. These findings identify cultural sensitivity training and cultural exposure as actionable targets for strengthening cross-cultural skillfulness in the medical curriculum.
- 31 October 2026
- Published by Springer Nature in BMC Medical Education
- Vol. 26 (1) , 1760
Open AccessCross-cultural care awareness and self-perceived skillfulness among medical students in Egypt: a national study
Background: Cross-cultural care (CCC) enables effective, patient-centered care for individuals from diverse backgrounds. Despite its importance in improving care quality and reducing health disparities, evidence on CCC among medical students in Egypt remains scarce. This study assessed medical students' cross-cultural self-perceived skillfulness and cultural awareness, examined their association, and identified sociodemographic and educational factors linked to both. Methods: A multicentric cross-sectional study was conducted between November 2025 and March 2026 across 14 Egyptian medical schools. Using convenience sampling, 1,645 medical students from all academic years and interns participated. Data were collected using an online questionnaire that included sociodemographic and educational factors, the Modified Cultural Awareness Scale (mCAS), and the Harvard CCC Survey skillfulness subscale. Statistical analyses included correlation, group comparisons, and multivariable linear regression. Results: Among 1,645 participants (mean age 21.8 ± 1.9 years; 53.7% female), the mean self-perceived cross-cultural skillfulness score was 3.55/5 (SD 0.78). Students felt most skilled in identifying a patient's Arabic literacy and taking a social history, and least skilled in counseling on complementary and alternative medicine and identifying patient mistrust. The mean total cultural awareness score was 4.69/7 (SD 0.75), highest in the Cognitive Awareness and Clinical Issues domains and lowest in General Educational and Research Experience. Higher awareness was associated with advanced English fluency and greater perceived adequacy of clinical experience and training (all p < 0.001), and skillfulness correlated positively with total awareness ( r = 0.383, p < 0.001). In multivariable analysis, advanced English fluency, prior cultural sensitivity training, and all four cultural awareness domains were independently associated with skillfulness (all p ≤ 0.036). Conclusion: Among medical students in Egypt, self-perceived cross-cultural skillfulness was at an intermediate level and was independently associated with advanced English fluency, prior cultural sensitivity training, and greater cultural awareness across all mCAS domains. These findings identify cultural sensitivity training and cultural exposure as actionable targets for strengthening cross-cultural skillfulness in the medical curriculum.
- 5 August 2026
- Published by Taylor & Francis in Disability and Rehabilitation
- p. 1-14
Measurements and management of multiple sclerosis-related fatigue: an umbrella review and meta-analysis
Multiple sclerosis (MS) is an autoimmune-mediated disorder of the central nervous system (CNS) where inflammation, demyelination, and neurodegeneration occur [1]. It is considered the most common n...
- 5 August 2026
- Published by Taylor & Francis in Disability and Rehabilitation
- p. 1-14
Measurements and management of multiple sclerosis-related fatigue: an umbrella review and meta-analysis
Multiple sclerosis (MS) is an autoimmune-mediated disorder of the central nervous system (CNS) where inflammation, demyelination, and neurodegeneration occur [1]. It is considered the most common n...
- 30 May 2026
- Published by Taylor & Francis in Neurodegenerative Disease Management
- p. 1-16
Bright light therapy for depression and excessive daytime sleepiness in Parkinson’s disease: a systematic review and meta-analysis of randomized controlled trials with dose-response meta-regression
Non-motor symptoms, including depression and excessive daytime sleepiness (EDS), reduce quality of life in Parkinson's disease (PD). Pharmacological treatments may cause side-effects, highlighting the need for non-pharmacological approaches. We conducted an updated meta-analysis with linear and non-linear dose-response meta-regression to evaluate bright light therapy (BLT) on depression and EDS in PD. PubMed, Scopus, and WOS were systematically searched through September 2025. Risk of bias was assessed using RoB-2 and NIH single-arm tools. Mean difference (MD) or standardized mean difference (SMD) with 95%confidence intervals (CI) were pooled using fixed-effects models. Linear and non-linear dose-response meta-regressions were performed. Eight studies were identified, six included in meta-analysis. For EDS, five studies (n = 159) showed no significant effect of BLT (MD =-1.14, 95%CI [-2.43, 0.15], p = 0.083, I2 = 0%), with no linear (p = 0.78) or non-linear (p = 0.97) dose-response relationship. For depression, five studies (n = 194) also showed no significant effect (SMD =-0.13, 95%CI [-0.41, 0.16], p = 0.38, I2 = 0%), without linear (p = 0.82) or non-linear (p = 0.85) associations. Sensitivity analyses were consistent. BLT was not associated with significant improvement in depression or EDS in PD, and no dose-response relationship was identified. Given methodological limitations, BLT cannot currently be recommended for clinical use. Future standardized dose-finding trials stratified by disease stage and retinal/ipRGC integrity are needed.
- 30 May 2026
- Published by Taylor & Francis in Neurodegenerative Disease Management
- p. 1-16
Bright light therapy for depression and excessive daytime sleepiness in Parkinson’s disease: a systematic review and meta-analysis of randomized controlled trials with dose-response meta-regression
Non-motor symptoms, including depression and excessive daytime sleepiness (EDS), reduce quality of life in Parkinson's disease (PD). Pharmacological treatments may cause side-effects, highlighting the need for non-pharmacological approaches. We conducted an updated meta-analysis with linear and non-linear dose-response meta-regression to evaluate bright light therapy (BLT) on depression and EDS in PD. PubMed, Scopus, and WOS were systematically searched through September 2025. Risk of bias was assessed using RoB-2 and NIH single-arm tools. Mean difference (MD) or standardized mean difference (SMD) with 95%confidence intervals (CI) were pooled using fixed-effects models. Linear and non-linear dose-response meta-regressions were performed. Eight studies were identified, six included in meta-analysis. For EDS, five studies (n = 159) showed no significant effect of BLT (MD =-1.14, 95%CI [-2.43, 0.15], p = 0.083, I2 = 0%), with no linear (p = 0.78) or non-linear (p = 0.97) dose-response relationship. For depression, five studies (n = 194) also showed no significant effect (SMD =-0.13, 95%CI [-0.41, 0.16], p = 0.38, I2 = 0%), without linear (p = 0.82) or non-linear (p = 0.85) associations. Sensitivity analyses were consistent. BLT was not associated with significant improvement in depression or EDS in PD, and no dose-response relationship was identified. Given methodological limitations, BLT cannot currently be recommended for clinical use. Future standardized dose-finding trials stratified by disease stage and retinal/ipRGC integrity are needed.
- 15 May 2026
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 126 (6) , 1947-1966
Therapeutic effects of cannabinoids on Parkinson’s disease: an updated systematic review and meta-analysis of randomized controlled trials
Current treatments for Parkinson's disease (PD) are primarily symptomatic and may lead to motor fluctuations and levodopa-induced dyskinesia over time, highlighting the need to repurpose other medications. Cannabinoids have gained attention as potential repurposed treatments. This systematic review and meta-analysis evaluated their efficacy in PD while addressing limitations of previous reviews, including low statistical power and inclusion of cannabinoid antagonists in pooled analyses. A literature search was conducted through PubMed, Scopus, and Web of Science, identifying randomized controlled trials (RCTs) evaluating the use of cannabinoids in PD. Quality assessment was done via RoB-2. A random-effects meta-analysis was performed using the meta and metafor packages in R, with mean differences (MD) or standardized mean differences (SMD; Hedges' g) reported with 95% confidence interval (CI). A sensitivity analysis was carried out to assess the robustness of our findings. In crossover trials, effect sizes and standard errors were extrapolated from the reported CIs, considering the paired design. Eleven RCTs were identified, six of which were eligible for meta-analysis due to the absence of poolable outcomes in the remainder. Cannabinoids did not significantly improve PD severity (SMD = 0.16, 95% CI[-0.13 to 0.44], p = 0.27, I²=0%), motor examination (SMD=-0.08, 95% CI[-0.35 to 0.20], p = 0.57, I²=0%), motor experiences of daily living (SMD=-0.08, 95% CI[-0.49 to 0.33], p = 0.71, I²=0%), non-motor symptoms (SMD= -0.03, 95% CI[-0.72 to 0.67], p = 0.94, I²= 64.3%). Sensitivity analysis excluding Peball et al. showed that the pooled estimate of non-motor symptoms was largely driven by nabilone (SMD = 0.34, 95%CI [-0.19 to 0.88], p = 0.21, I²=0%), suggesting a drug-specific benefit signal. Cannabinoids have not shown significant benefit in PD; however, our findings should be interpreted with caution. The nabilone benefit signal for non-motor symptoms represents a distinct question warranting dedicated trials. Future studies should use standardized, pharmacologically stratified protocols.
- 15 May 2026
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 126 (6) , 1947-1966
Therapeutic effects of cannabinoids on Parkinson’s disease: an updated systematic review and meta-analysis of randomized controlled trials
Current treatments for Parkinson's disease (PD) are primarily symptomatic and may lead to motor fluctuations and levodopa-induced dyskinesia over time, highlighting the need to repurpose other medications. Cannabinoids have gained attention as potential repurposed treatments. This systematic review and meta-analysis evaluated their efficacy in PD while addressing limitations of previous reviews, including low statistical power and inclusion of cannabinoid antagonists in pooled analyses. A literature search was conducted through PubMed, Scopus, and Web of Science, identifying randomized controlled trials (RCTs) evaluating the use of cannabinoids in PD. Quality assessment was done via RoB-2. A random-effects meta-analysis was performed using the meta and metafor packages in R, with mean differences (MD) or standardized mean differences (SMD; Hedges' g) reported with 95% confidence interval (CI). A sensitivity analysis was carried out to assess the robustness of our findings. In crossover trials, effect sizes and standard errors were extrapolated from the reported CIs, considering the paired design. Eleven RCTs were identified, six of which were eligible for meta-analysis due to the absence of poolable outcomes in the remainder. Cannabinoids did not significantly improve PD severity (SMD = 0.16, 95% CI[-0.13 to 0.44], p = 0.27, I²=0%), motor examination (SMD=-0.08, 95% CI[-0.35 to 0.20], p = 0.57, I²=0%), motor experiences of daily living (SMD=-0.08, 95% CI[-0.49 to 0.33], p = 0.71, I²=0%), non-motor symptoms (SMD= -0.03, 95% CI[-0.72 to 0.67], p = 0.94, I²= 64.3%). Sensitivity analysis excluding Peball et al. showed that the pooled estimate of non-motor symptoms was largely driven by nabilone (SMD = 0.34, 95%CI [-0.19 to 0.88], p = 0.21, I²=0%), suggesting a drug-specific benefit signal. Cannabinoids have not shown significant benefit in PD; however, our findings should be interpreted with caution. The nabilone benefit signal for non-motor symptoms represents a distinct question warranting dedicated trials. Future studies should use standardized, pharmacologically stratified protocols.
- Top Cited PapersOpen Access
- 9 March 2026
- Published by Springer Nature in Advances in Health Sciences Education
- p. 1-27
The impostor phenomenon construct in medical education: a meta-analysis of its prevalence and a critical appraisal of its measurement
Impostor phenomenon (IP) is widely cited as a significant challenge in medical education, yet its conceptual and methodological foundations are unstable, hindering a clear understanding of its true scope and impact. Thus, this systematic review and meta-analysis aimed to first establish a pooled prevalence of IP among medical students, and second, to critically appraise the measurement tools and definitions used in the literature. We systematically searched PubMed, Scopus, Web of Science, and CINAHL through July 2025 for all studies quantitatively assessing IP prevalence in medical students. Using a random-effects model, we analyzed data from 34 studies, including 9,550 participants. The overall pooled prevalence of IP was 49% (95% CI [0.43–0.54]), but this figure is complicated by extreme heterogeneity across studies (I 2 =95.6%, P < 0.001) despite multiple sensitivity analyses. Subgroup analyses revealed significant prevalence differences by gender (females 51% vs. males 40%; P = 0.021), geographic region ( P < 0.001), and the measurement tool used ( P < 0.001). The qualitative synthesis suggested associations between IP and negative mental health outcomes, including anxiety, depression, and burnout. Nevertheless, the variance driven by different measurement tools suggests that researchers may not be consistently measuring the same construct. The reliance on unvalidated cutoffs further weakens the validity of prevalence estimates. We conclude that while IP is clearly a prevalent concern, the construct’s weak theoretical grounding and inconsistent measurement impede meaningful progress. Advancing this area of medical education research requires a foundational shift toward conceptual clarity and methodological rigor.
- 9 March 2026
- Published by Springer Nature in Advances in Health Sciences Education
- p. 1-27
Top Cited PapersOpen AccessThe impostor phenomenon construct in medical education: a meta-analysis of its prevalence and a critical appraisal of its measurement
Impostor phenomenon (IP) is widely cited as a significant challenge in medical education, yet its conceptual and methodological foundations are unstable, hindering a clear understanding of its true scope and impact. Thus, this systematic review and meta-analysis aimed to first establish a pooled prevalence of IP among medical students, and second, to critically appraise the measurement tools and definitions used in the literature. We systematically searched PubMed, Scopus, Web of Science, and CINAHL through July 2025 for all studies quantitatively assessing IP prevalence in medical students. Using a random-effects model, we analyzed data from 34 studies, including 9,550 participants. The overall pooled prevalence of IP was 49% (95% CI [0.43–0.54]), but this figure is complicated by extreme heterogeneity across studies (I 2 =95.6%, P < 0.001) despite multiple sensitivity analyses. Subgroup analyses revealed significant prevalence differences by gender (females 51% vs. males 40%; P = 0.021), geographic region ( P < 0.001), and the measurement tool used ( P < 0.001). The qualitative synthesis suggested associations between IP and negative mental health outcomes, including anxiety, depression, and burnout. Nevertheless, the variance driven by different measurement tools suggests that researchers may not be consistently measuring the same construct. The reliance on unvalidated cutoffs further weakens the validity of prevalence estimates. We conclude that while IP is clearly a prevalent concern, the construct’s weak theoretical grounding and inconsistent measurement impede meaningful progress. Advancing this area of medical education research requires a foundational shift toward conceptual clarity and methodological rigor.
- 12 January 2026
- Published by The R Foundation
MetaDose: Dose-Response Meta-Regression for Meta-Analysis
Conducting linear and nonlinear dose-response meta-regression using study-level summary data. It supports both continuous and binary outcomes and allows modeling of dose-effect relationships using linear trends or nonlinear restricted cubic splines. The package is designed to facilitate transparent, flexible, and reproducible dose-response meta-analyses, with built-in visualization of fitted dose-response curves.
- 12 January 2026
- Published by The R Foundation
MetaDose: Dose-Response Meta-Regression for Meta-Analysis
Conducting linear and nonlinear dose-response meta-regression using study-level summary data. It supports both continuous and binary outcomes and allows modeling of dose-effect relationships using linear trends or nonlinear restricted cubic splines. The package is designed to facilitate transparent, flexible, and reproducible dose-response meta-analyses, with built-in visualization of fitted dose-response curves.
- 10 September 2025
- Published by The R Foundation
metagroup: Meaningful Grouping of Studies in Meta-Analysis
Performs meaningful subgrouping in a meta-analysis. This is a two-step process; first, use the iterative grouping functions (e.g., mgbin(), mgcont() ) to partition studies into statistically homogeneous clusters based on their effect size data. Second, use the meaning() function to analyze these new subgroups and understand their composition based on study-level characteristics (e.g., country, setting). This approach helps to uncover hidden structures in meta-analytic data and provide a deeper interpretation of heterogeneity.
- 10 September 2025
- Published by The R Foundation
metagroup: Meaningful Grouping of Studies in Meta-Analysis
Performs meaningful subgrouping in a meta-analysis. This is a two-step process; first, use the iterative grouping functions (e.g., mgbin(), mgcont() ) to partition studies into statistically homogeneous clusters based on their effect size data. Second, use the meaning() function to analyze these new subgroups and understand their composition based on study-level characteristics (e.g., country, setting). This approach helps to uncover hidden structures in meta-analytic data and provide a deeper interpretation of heterogeneity.